SCHEMBL15538258

SCHEMBL15538258

CC(C)(F)CN1CCC(COc2ccc(-c3ccc(C(=O)O)c(F)c3)nn2)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 3/20 0.43
BCHE P06276 2/20 0.41
ACHE P22303 2/20 0.41
FFAR4 Q5NUL3 6/20 0.39
CHRM4 P08173 2/20 0.38
CHRM2 P08172 1/20 0.38
CHRM5 P08912 1/20 0.38
CHRM1 P11229 1/20 0.38
CHRM3 P20309 1/20 0.38
SSTR5 P35346 1/20 0.37
KCNH2 Q12809 1/20 0.37
DYRK1A Q13627 2/20 0.36
PDK1 Q15118 1/20 0.36
PDK2 Q15119 1/20 0.36
PDK3 Q15120 1/20 0.36
PDK4 Q16654 1/20 0.36
RARA P10276 1/20 0.36
RARB P10826 1/20 0.36
SCN7A Q01118 1/20 0.36
GSK3B P49841 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15539069 0.90 GPR119 (0.41) GPR119BCHEACHEFFAR4CHRM4
SCHEMBL20053643 0.90 GPR119 (0.43) GPR119BCHEACHEFFAR4KCNH2
SCHEMBL15539379 0.88 GPR119 (0.45) GPR119FFAR4CHRM4CHRM2CHRM5
SCHEMBL15538426 0.87 DYRK1A (0.43) GPR119ACHECHRM4CHRM2CHRM5
SCHEMBL15539714 0.86 ACHE (0.45) GPR119BCHEACHESSTR5KCNH2
SCHEMBL15539598 0.86 GPR119 (0.59) GPR119CHRM2CHRM5CHRM1CHRM3
SCHEMBL15538905 0.85 PIK3CA (0.41) GPR119PDK1PDK2PDK3PDK4
SCHEMBL15538907 0.85 PIK3CA (0.41) GPR119PDK1PDK2PDK3PDK4
SCHEMBL15539058 0.85 CNR2 (0.39) GPR119FFAR4PDK1PDK2PDK3
SCHEMBL15539062 0.85 CNR2 (0.39) GPR119FFAR4PDK1PDK2PDK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2858986-B1 PIPERIDINE DERIVATIVES AS GPR119 AGONISTS CHONG KUN DANG PHARMACEUTICAL CORP (KR) 2019-10-30 EP disclosed
US-9944600-B2 Piperidine derivatives for GPR119 agonist CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2018-04-17 US disclosed
US-20150166480-A1 PIPERIDINE DERIVATIVES FOR GPR119 AGONIST CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2015-06-18 US disclosed
EP-2858986-A1 PIPERIDINE DERIVATIVES FOR GPR119 AGONIST Chong Kun Dang Pharmaceutical Corp. (KR) 2015-04-15 EP disclosed
WO-2013187646-A1 PIPERIDINE DERIVATIVES FOR GPR119 AGONIST CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2013-12-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150166480-A1 PIPERIDINE DERIVATIVES FOR GPR119 AGONIST GPR119, FFAR2, GPR84 GPR119 1/4885BCHE 4249/4885ACHE 4244/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.